文献速递白血病

四基因长链非编码RNA表达特征可预测多队列急性髓系白血病患者风险

A four-gene LincRNA expression signature predicts risk in multiple cohorts of acute myeloid leukemia patients.
PubMed 文献 · Leukemia · 2017-07-04

研究分析多个临床注释的急性髓系白血病(AML)患者队列转录组数据,发现用于编码基因表达的微阵列可重用于获取稳健的长链非编码RNA(lincRNA)表达数据;由三或四个基因组成的lincRNA特征可独立预测临床结局,并进一步区分欧洲白血病网(ELN)风险组的生存;基于四个lincRNA基因(LINC4)定量PCR的logistic回归分析工具可用于确定AML风险。

要点

  • 用于编码基因表达的微阵列可重用于获取稳健的lincRNA表达数据。
  • 三或四基因lincRNA特征可独立预测AML临床结局并进一步区分ELN风险组生存。
  • 基于四个lincRNA基因(LINC4)定量PCR的logistic回归分析工具可用于确定AML风险。

核心结论

  • 四基因lincRNA表达特征(LINC4)可预测多队列AML患者风险并进一步区分ELN风险组生存。

研究设计与样本

  • 分析多个队列的临床注释AML患者转录组数据。

主要发现

  • 用于编码基因表达的微阵列可重用于产生稳健的lincRNA表达数据。
  • 一些lincRNA基因位于造血编码基因附近并在AML中显示强表达相关性。
  • lincRNA基因表达模式可区分AML的细胞遗传学和分子亚型。
  • 由三或四个基因组成的lincRNA特征可独立预测临床结局并进一步区分ELN风险组生存。
  • 基于四个lincRNA基因(LINC4)定量PCR的logistic回归分析工具可用于确定AML风险。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Prognostic gene expression signatures have been proposed as clinical tools to clarify therapeutic options in acute myeloid leukemia (AML). However, these signatures rely on measuring large numbers of genes and often perform poorly when applied to independent cohorts or those with older patients. Long intergenic non-coding RNAs (lincRNAs) are emerging as important regulators of cell identity and oncogenesis, but knowledge of their utility as prognostic markers in AML is limited. Here we analyze transcriptomic data from multiple cohorts of clinically annotated AML patients and report that (i) microarrays designed for coding gene expression can be repurposed to yield robust lincRNA expression data, (ii) some lincRNA genes are located in close proximity to hematopoietic coding genes and show strong expression correlations in AML, (iii) lincRNA gene expression patterns distinguish cytogenetic and molecular subtypes of AML, (iv) lincRNA signatures composed of three or four genes are independent predictors of clinical outcome and further dichotomize survival in European Leukemia Net (ELN) risk groups and (v) an analytical tool based on logistic regression analysis of quantitative PCR measurement of four lincRNA genes (LINC4) can be used to determine risk in AML.

来源:Leukemia,查看原文。版权归原作者所有。

引用

  1. Beck D, Thoms JAI, Palu C, et al. A four-gene LincRNA expression signature predicts risk in multiple cohorts of acute myeloid leukemia patients. Leukemia. 2017. PMID: 28674423. doi:10.1038/leu.2017.210

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。